UNITED STATES
                           SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C.  20549

                                        FORM 12b-25
                                 NOTIFICATION OF LATE FILING
                                                                          
SEC File No.
                                                                         
    0-12258 

CUSIP No.

163611-304
                                                                        
                                                                           
  Form 10-K     Form 20-F     Form 11-K   X Form 10-Q       Form N-SAR

                  For Period Ended:      November 30, 1997  


PART I - REGISTRANT INFORMATION

                     Chemfix Technologies, Inc.                            
                                            
Full Name of Registrant

                                                                           
                                                     
Former Name if Applicable

               3500 N. Causeway Blvd., Suite 1280                         
                                   
Address of Principal Executive Office (Street and Number)

              Metairie, LA  70002                                         
                                               
City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to rule 12b-25(b), the
following should be completed. (Check box if appropriate)

         (a)      The reasons described in reasonable detail in Part III of
                  this form could not be eliminated without unreasonable
                  effort or expense;
 X       (b)      The subject annual report, semi-annual report, transition 
                  report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion 
                  thereof, will be filed on or before the fifteenth calendar
                  day following the prescribed due date; or the subject 
                  quarterly report of transition report on Form 10-Q, or 
                  portion thereof will be filed on or before the fifth 
                  calendar day following the prescribed due date; and
         (c)      The accountant's statement or other exhibit required by Rule
                  12b-25(c) has been attached if applicable. 

PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within 
the prescribed time period.

         Due to serious financial problems, the Registrant's accounting staff 
         have been terminated which in turn has caused delays in completing
         first quarter financials and subsequently a delay in filing the
         Registrant's Form 10-Q. Therefore, we are requesting a 30-day
         extension.

PART IV - OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this 
     notification 

          David L. Donaldson                (504)               831-3600   
             (Name)                       (Area Code)       (Telephone Number)

(2)      Have all other periodic reports required under Section 13 or 15(b)
         of the Securities Exchange Act of 1934 or Section 30 of the 
         Investment Company Act of 1940 during the preceding 12 months
         (or for such shorter) period that the registrant was required 
         to file such reports) been filed?  If answer is no, identify 
         report(s).
                                                         X  Yes     No
                                                                        
                         

(3)      Is it anticipated that any significant change in results of 
         operations from the corresponding period for the last fiscal 
         year will be reflected by the earnings statements to be included 
         in the subject report or portion thereof?
                                                           Yes  X  No

         If so, attach an explanation of the anticipated change, both 
         narratively and quantitatively, and, if appropriate, state the 
         reasons why a reasonable estimate of the results cannot be made.

                                                                           
                                                     


                             Chemfix Technologies, Inc.                    
                    (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned 
hereunto duly authorized. 

Date  January 15, 1998                  By                               
                                        David L. Donaldson, President and CEO

INSTRUCTION:  The form may be signed by an executive officer of the registrant
or by any other duly authorized representative.  The name and title of the 
person signing the form shall be typed or printed beneath the signature.  
If the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the 
representative's authority to sign on behalf of the registrant shall be filed 
with the form.